Vmbook Online ordering

Icons

**Company Overview**

**Name:** Icon plc

**Ticker Symbol:** BADGE-CC

**Exchange:** Nasdaq Global Select Market

**Industry:** Medical Technology

**Business Description:**

Icon is a global provider of clinical research services to the pharmaceutical, biotechnology, and medical device industries. The company offers a range of services, including clinical trial design, conduct, and data management.

**Key Financials:**

* **Revenue (2022):** $3.6 billion

* **Net Income (2022):** $286 million

* **Earnings Per Share (2022):** $1.90

**Growth and Earnings:**

* Icon has experienced strong growth in recent years, driven by increasing demand for clinical research services.

* The company's revenue has grown at a compound annual growth rate (CAGR) of approximately 10% over the past five years.

* Icon's earnings per share have also grown at a CAGR of approximately 15% over the same period.

**Dividend:**

Icon does not currently pay a dividend.

**Valuation:**

* As of March 8, 2023, Icon's market capitalization is approximately $11.6 billion.

* The company's stock is trading at a price-to-earnings (P/E) ratio of approximately 35.

**Other Key Points:**

* Icon is headquartered in Dublin, Ireland, and has operations in over 50 countries.

* The company employs approximately 18,000 people worldwide.

* Icon has a strong track record of innovation and has developed several proprietary technologies to improve clinical trial efficiency.

* The company faces competition from other large clinical research organizations, such as CRO, Parexel, and PPD.